Management of adults with paediatric-onset chronic liver disease: strategic issues for transition care

Pietro Vajro1, Lorenza Ferrante2, Selvaggia Lenta3

  • 1Chair of Paediatrics, Department of Medicine and Surgery, University of Salerno, Baronissi (Salerno), Italy.

Insights

Many children with chronic liver disease now survive into adulthood, presenting unique challenges for adult hepatology. This review covers pediatric-onset liver conditions to improve adult care and patient transition.

Area of Science:

  • Hepatology
  • Pediatric Gastroenterology
  • Internal Medicine

Background:

  • Advances in pediatric chronic liver disease management allow more patients to reach adulthood.
  • Adult hepatology practices are increasingly encountering patients with conditions originating in childhood.
  • Pediatric-onset liver diseases often present differently than adult-onset conditions, requiring specialized knowledge.

Purpose of the Study:

  • To provide adult healthcare providers with comprehensive knowledge of pediatric-onset chronic liver diseases.
  • To outline the causes, presentations, evaluation, and management of these conditions.
  • To discuss key considerations for transitioning care from pediatric to adult settings.

Main Methods:

  • Review of existing literature on pediatric-onset chronic liver diseases.
  • Examination of clinical manifestations, diagnostic approaches, and therapeutic strategies.
  • Discussion of complications and long-term management needs.

Main Results:

  • Paediatric-onset liver diseases have diverse aetiologies and clinical presentations.
  • Adult physicians may be unfamiliar with the specific manifestations and management nuances.
  • Effective transition requires a thorough understanding of the disease spectrum and care differences.

Conclusions:

  • Adult medical staff need specialized knowledge of childhood liver diseases for optimal patient care.
  • Guidelines are needed to standardize the transition of care for these patients.
  • This review aims to facilitate the development of structured transition programs.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
563
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
631
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
884
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967